No profile data available.
Glaukos Corporation (GKOS) is a healthcare company in the targeted healthcare equipment industry, based in Aliso Viejo, United States, with about 1,094 full-time employees.
It reported revenue of $507.44 million for fiscal year 2025, up 32.3% from fiscal year 2024, and net income of -$187.69 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $185.61 million, up 49.5% from a year before. United States was its largest region in fiscal year 2025, with 74% of revenue. Its market capitalization was $9.77 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States and internationally.
Glaukos reported $507.44 million in revenue for fiscal year 2025, up 32.3% from $383.48 million in fiscal year 2024. In Q2 2026 revenue was $185.61 million.
United States: 74% of revenue by region in fiscal year 2025, followed by International (26%).
$9.77 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (targeted healthcare equipment) include Alcon Inc. (ALC), Penumbra, Inc. (PEN), The Cooper Companies, Inc. (COO), Lantheus Holdings, Inc. (LNTH).